エピソード

  • CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection

    CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection
    2025/09/24
    Sponsored by Bristol Myers Squibb.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    25 分
  • Practical considerations in the management of early rrMM in the Canadian context

    Practical considerations in the management of early rrMM in the Canadian context
    2025/01/06

    This podcast features Dr. Christopher Venner and his colleagues from the hematology community, Dr. Sylvia McCulloch, Dr. Arleigh McCurdy, and Dr. Chai Phua discussing the approach to the management of early rrMM in the Canadian context.


    This episode of Science for the Real World is part of Canadian Hematology Today, an open-access scientific journal for the hematology community.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    32 分
  • The role of selinexor in early rrMM and sequencing in 2024.

    The role of selinexor in early rrMM and sequencing in 2024.
    2024/06/26

    In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing.


    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    28 分